Vivitrol FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 28, 2021.
FDA Approved: Yes (First approved April 13, 2006)
Brand name: Vivitrol
Generic name: naltrexone
Dosage form: for Extended-Release Injectable Suspension
Previous Name: Vivitrex
Company: Alkermes, Inc.
Treatment for: Alcohol Dependence, Opiate Dependence
Vivitrol (naltrexone) is is an opioid antagonist indicated for the treatment of alcohol dependence and opioid dependence.
Development Timeline for Vivitrol
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.